Evidence mapPaperPMID 42500730Full record

ArticleSmart molecules : open access2026

Innovative 3D-bioprinted microfibers in calcium phosphate cement platform with Nell-1 to activate nerve-bone axis for synergistic bone, vasculature, and nanofibrous nerve regeneration.

Minjia Zhu, Xinyi Li, Jingyi Li, Kan Yu, Zixiang Dai, Le Xiao, Qinrou Zhang, Zihan Jia, Qingchen Qiao, Zeqing Zhao and 2 more

Abstract read
In one paragraph

Article in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Minjia ZhuDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Xinyi LiDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Jingyi LiDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Kan YuDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Zixiang DaiDepartment of Dentistry Beijing Friendship Hospital Capital Medical University Beijing China.
Le XiaoDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Qinrou ZhangDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Zihan JiaDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Qingchen QiaoDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Zeqing ZhaoDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.
Ke ZhangDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.ORCID https://orcid.org/0000-0001-7982-5758
Yuxing BaiDepartment of Orthodontics School of Stomatology Beijing Stomatological Hospital Capital Medical University Beijing China.ORCID https://orcid.org/0000-0002-7239-0891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Critical-sized bone defects remain a persistent clinical challenge, primarily because conventional scaffolds fail to reproduce the nanofibrous neurovascular architecture that underlies functional bone regeneration. Here, we present a breakthrough 3D-bioprinted platform combining alginate microfibers (aMF) laden with human periodontal ligament stem cells (hPDLSCs) and a calcium phosphate cement (CPC) matrix, creating a hybrid environment that bridges mechanical stability with nanofibrous neurovascular guidance. This platform is engineered for the spatiotemporal delivery of Nell-1, which uniquely activates a novel "nerve-bone" axis. Nell-1 engagement initiates a CYFIP1-mediated CGRP-β3 tubulin cascade that amplifies neurovascular and bone crosstalk. A dual-phase release profile emerges as a critical design feature, with early signaling creating a favorable microenvironment for neurovascular infiltration, and then sustain signaling over time. Together, these phases synergistically enhance osteogenesis by a 2-fold increase, angiogenesis by a 3-fold increase, and innervation by a 2-fold increase. When tested in rat cranial defects, our construct outperformed controls by doubling bone and nerve regeneration while tripling vascular density, thereby achieving unprecedented healing rates compared to existing approaches. Mechanistically, we redefine Nell-1 as a dual osteo-neurogenic regulator, leveraging endogenous stem cells to drive structural and functional repair. This 3D-bioprinted microfiber-in-CPC system advances beyond passive scaffolds by dynamically coupling structural support with bioactive signaling, offering a transformative strategy for neuro-vascularized bone reconstruction.

Indexed as

angiogenesisbone tissue engineeringinnervationnanofibersNell‐1“nerve‐bone”axisosteogenesis

Identifiers

PMID42500730
PMCPMC13398944

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.